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Treatment WITH Cocaine Analogs. Tobias T. Lee, Peter Jadow, and Charles W. 
Bradberry. Departments of Laboratory Medicine and Psychiatry, Yale University , School 
of Medicine, New Haven, CT. 
ABSTRACT: The search for a pharmacologic treatment of cocaine addiction has lead to 
the study of possible cocaine analogs to be used as substitution therapy, much like 
methadone is used in heroin addiction. The goal is to identify compounds which may 
produce cross-tolerance to cocaine and thus blunt cocaine’s euphoric effects. The effects of 
acute (three hours) and chronic (seven days) exposure to intravenous cocaine, cocaethylene, 
or isopropyl cocaine on the response to a subsequent cocaine challenge were examined. 
Neurochemical (microdialysis nucleus accumbens dopamine level measurements) and 
behavioral (locomotor activity) measures were compared. The relative potency of 
isopropyl cocaine compared to cocaine in the anesthetized rat was also examined. The 
results of the acute tolerance experiments showed no behavioral tolerance in any group; 
however, there was a decrease in dopamine response to a cocaine challenge in the cocaine- 
and cocaethylene-pretreated groups. Though acute neurochemical tolerance was suggested, 
these data need to be interpreted with caution as the cocaine pretreatment group had a 
sustained, high baseline during the three hour maintenance which may be the animals’ 
maximal response to cocaine. Cocaethylene seemed to produce acute tolerance to itself 
during the three hour maintenance phase as neither the neurochemical nor the behavioral 
effects were sustained. Chronically, cocaine- and cocaethylene-pretreated animals 
demonstrated a reduced response to a subsequent cocaine challenge compared to placebo; 
the isopropyl cocaine pretreated animals behaved no differently from the placebo group. 
Isopropyl cocaine is much less potent than cocaine in its ability to elevate dopamine in 
both awake and anesthetized animals. Most significantly, these studies show that behavioral 
tolerance was achieved after one week of cocaethylene pretreatment. Cocaethylene or its 
related analogs shows some promise as a possible pharmacological treatment of cocaine 
addiction as chronic treatment blunts the subsequent effects of cocaine. 
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1. INTRODUCTION 
The 1985 National Household Survey on Drug Abuse estimated the number of 
individuals over the age of 12 that have tried cocaine to be approximately 25 million in 
the United States (1988). This increasing problem has lead to continued interest in 
research in both cocaine and its analogs, both to understand the nature and effects of cocaine 
and also to search for possible pharmacological modalities to treat cocaine dependence 
(Leshner, 1996; Seifert/., 1996). 
Currently there are no effective treatments for cocaine addiction. Studies 
evaluating the treatment ol this illness with nonpharmacological methods such as talk 
therapy or acupuncture have yielded poor results so lar. While effective medications have 
yet to be identified, the approaches for finding a pharmacological treatment for cocaine 
addiction have been many: some researchers search for an agent that would treat the 
addiction by acting as a cocaine antagonist much like naloxone acts in opioid overdoses, 
others explore the use ot antidepressants to decrease craving and subsequent drug-seeking 
behavior as with buproprion for treatment of nicotine addiction. In this thesis, compounds 
which can induce cross-tolerance to subsequent cocaine use are examined to see il these 
cocaine analogs have potential for therapy. If tolerance to cocaine can be successfully shown 
to occur with chronically administered cocaethylene or isopropyl cocaine, then there may 
be a potential benefit if these or other cocaine analog can be used to treat cocaine abusers 
much in the same way that methadone is used currently to maintain heroin addicts. 
It is presently believed that cocaine and other psychoactive drugs cause 
reinforcement in animals and presumably euphoria in humans through the elevation of 
dopamine levels in the nucleus accumbens; cocaine is also known to elevate extracellular 
concentrations of other monoamine neurotransmitters (Bradberry et al., 1993; Koob and 
Bloom, 1988; Ritz et al, 1987). The increases in extracellular neurotransmitter 
concentrations are believed to be due to cocaine’s binding to monoamine transporters 
thereby preventing dopamine, norepinephrine, and serotonin reuptake after initial release 
(Hammer and Cooke, 1994). 
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Drug tolerance is defined as an attenuation of drug responsiveness resulting from 
prior exposure to the drug (Pan et al., 1991). By producing tolerance in an experimental 
subject, a constant amount ol cocaine will produce a reduced euphoric effect. Numerous 
studies have demonstrated tolerance in the rat model with chronic cocaine administration 
(Emmett-Oglesby et al., 1993; Frank et al., 1992; Katz et al., 1992; Masserano et al, 
1994). 
Between 70% and 80% of cocaine abusers concurrently use ethanol (Grant and 
Harford, 1990). Cocaethylene is a cocaine analog and metabolite formed in vivo following 
concurrent cocaine and ethanol consumption as a result of enzymatic transesterification 
(Bailey, 1993; Boyer and Petersen, 1992; Dean et al., 1991; Jatlow et al., 1991). It is 
pharmacologically active and produces a euphoric effect in humans that is similar to 
cocaine but is eliminated more slowly (Bradberry et al., 1993; Hearn et al., 1991; 
McCance et al., 1995; McCance-Katz et al., 1993). Cocaethylene binds equipotently to 
cocaine at dopamine transporters but exhibits a lower binding alfinity to serotonin 
transporters than cocaine (Elsworth et al, 1993; Hearn et al., 1991). Isopropyl cocaine is an 
analog of cocaine with an isopropyl moiety substituted for the methyl group. Many ol the 
properties of isopropyl cocaine are currently under study. This analog is even more 
selective for the dopamine transporter than cocaethylene (Elsworth et al., 1993; Jatlow, 
1993). Differences in monoamine transporter selectivity may alter the neurotransmitter 
pattern of neurochemical tolerance resulting from effects of cocaine analogs, thus altering 
the subjective effects of subsequent cocaine. The structures of cocaine, cocaethylene, and 
isopropyl cocaine are presented in Figure 1. 
Three groups of experiments have been conducted in this study. Acute tolerance was 
examined in the first experiment. The effects of an intravenous bolus and constant infusion 
of cocaine or cocaine analog on a rat that is free to move about a cage followed by a 
cocaine challenge were examined. Extracellular dopamine levels in the nucleus accumbens 
were measured using the technique of microdialysis. These data were collected along with 
photocell measurements of rat locomotor activity. Second, the dopamine response in the 
nucleus accumbens of an anesthetized rat to challenges of cocaine or cocaine analog were 
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measured to compare the potency of isopropyl cocaine at increasing extracellular 
dopamine. Finally, the effects of a continuous seven day constant infusion of cocaine, 
cocaethylene, and isopropyl cocaine on the behavioral activation in animals given a 
subsequent challenge of cocaine were determined. This experiment addressed the issue of 
behavioral response to a cocaine challenge after a chronic pretreatment with an analog. 
The hypothesis to be tested was that continuous infusion of cocaine, cocaethylene, or 
isopropyl cocaine would blunt response to later cocaine challenge. Two different lengths of 
time for the maintenance phase were examined: one study included a three hour constant 
infusion phase while the other a week long period of pre-treatment. Also, further 
characterization of cocaine, cocaethylene, and isopropyl cocaine was performed. 
All experiments and procedures (including the construction and stereotactic 
insertion of the microdialysis probes) for this thesis were performed by me except for the 
post-mortem plasma drug analysis using extraction and HPLC which was performed in Dr. 
Jatlow’s laboratory and the tail vein injections during the anesthetized rat studies which 
were performed by Dr. Charles Bradberry. 
2. MATERIALS AND METHODS 
2.1 Introduction for Acute Tolerance Studies 
Male Sprague-Dawley rats (obtained from CAMM) weighing between 250-M50 
grams were used in these studies. Food and water were provided ad libitum at all times. 
All animal use procedures were in strict accordance with the NIH Guide for the Care and 
Use of Laboratory Animals (1985) and were approved by the local Animal Studies 
Committee. For the Acute Tolerance Studies, the animals were anesthetized during which 
time both a microdialysis guide cannula and a jugular catheter were implanted. The rat 
was allowed to recover for at least two full days but not longer than one week prior to 
studies. Preparation for an experiment included stereotactic insertion of the microdialysis 
probe in the nucleus accumbens through the guide cannula and connecting the animal to a 
liquid swivel in the cages; this procedure required minimal halothane administration. The 
rats were allowed to recover overnight during which behavioral data were collected. The 
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next day, extracellular dopamine concentrations in the nucleus accumbens were measured 
with in vivo microdialysis prior to, during, and subsequent to drug challenge at 20 minute 
intervals, and the number of non-consecutive breaks of infrared photo beams using an 
infrared detector was recorded at five minute intervals tor behavioral measurements; both 
were continued for the entire experiment. After a baseline of two hours, a bolus followed 
by a constant infusion of drug was administered through the jugular catheter. This first 
bolus and infusion of drug was cocaine, cocaethylene, or isopropyl cocaine respectively. 
Three hours later, a challenge of cocaine was given by bolus and dialysis samples were 
collected for another hour with no more drug administered. At the end of the hour the 
animal was sacrificed following equithesin anesthesia. Blood was collected, centrifuged, 
and the plasma was later analyzed. Probe placement was verified by analyzing 
postmortem, formaldehyde-fixed brains stained with cresyl violet and sliced in 100 fim 
sections. 
22 Surgery for Acute Tolerance Studies 
Rats were placed in an induction box and given 5% halothane mixed with 80% 
oxygen. Upon induction, it was immediately removed and given an intraperitoneal 
injection of equithesin (0.35 mL/100 gm) (see Table 1: Equithesin). The equithesin was 
allowed at least five minutes to take effect before the surgery began. Additional anesthetic 
was given as needed throughout the procedure to insure surgical anesthesia. Attention was 
paid to sterile technique. Rat body temperature was maintained with an electric heating 
pad set at 37° C. 
Table l: Equithesin 
nembutal (50 mg/mL pentobarbital) 16.20 mL 
chloral hydrate 4.25 gm 
propane-1,2-diol (propylene glycol) 39.60 mL 
absolute ethanol 10.00 mL 
add to volume of 100 mL with H2O 
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The fur above the skull and in the upper portions of the thorax was shaved; care was 
taken not to damage the whiskers so as not to affect behavior. An incision approximately 
1.5-2 cm in length was made along the right midclavicular line above the point where 
pulsation was found in the supine animal. Careful dissection yielded the jugular vein which 
was exposed. The vein was tied off with 2-0 silk surgical thread. The animal was then 
turned over, and an incision approximately 2 cm long was made midsagitally along the 
top of the skull. Using scissors, a subcutaneous path was made from the caudal aspect of the 
incision at the head to the exposed jugular vein. The jugular catheter was then passed 
through the subcutaneous path. A small nick was made in the jugular vein proximal to the 
occlusion and the jugular catheter was inserted to the right atrium of the heart. 
The jugular catheter was made with 13 cm of silastic medical grade tubing (Dow 
Corning, 0.020 inch i.d., 0.037 inch o.d.). At the end to be inserted into the jugular vein, 
two small beads of 6382 RTV Silicone Elastomer (Factor II, AZ) were placed 3.5 cm from 
the end to hold the catheter in position in vivo. The other end consisted of a piece of 23 
gauge tubing bent to form an L shape attached to the silastic tubing by multipurpose 
sealant (Dow Corning 732 RTV). Before surgery, heparinized saline was run into the jugular 
catheter to prevent air emboli. 
Once inserted to the beads, the jugular catheter was tied in place with more 
surgical thread. Proper placement was checked by syringe aspiration. A small amount of 
heparinized saline was then injected into the rat to clear the jugular cannula of blood and 
ensure patency. The rat was then placed in a stereotaxic frame after the thoracic wound was 
closed. 
After the rat was placed in the stereotaxic frame in the flat skull position, the skull 
was exposed from the previous incision by spreading the layers of the scalp using cotton 
swabs. An 18 gauge stainless-steel guide cannula of 8 mm length was implanted 1.0 mm 
below the skull surface over the nucleus accumbens using the coordinates AP +1.7 mm, L - 
1.5 mm, and V -8.3 mm from bregma (Paxinos and Watson, 1982). Two stainless-steel 
screws were placed "in the skull to secure the dental acrylic which anchored in place the 
microdialysis guide cannula, the jugular catheter L piece, and the slotted screw used by the 
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liquid swivel for awake animal experiments. The rats were then returned to their cages to 
recover from one to six days with free access to water and food before being placed in the 
experimental set-up. 
23 Microdialysis 
Concentric-style microdialysis probes (Bradberry et al., 1993; Bradberry and 
Roth, 1989; Johnson and Justice, 1983) were used. A hollow dialysis fiber (300 /^m i.d., 
330 gm o.d.) with one end epoxy-sealed and containing a fused silica fiber (102 /dm i.d., 
163 /dm o.d.) was housed in a 23 gauge (0.64 mm o.d.), thin-walled hypodermic tube. The 
outlet opening was through another piece of fused silica placed into the hypodermic tube. 
Epoxy was applied as sealant at the end of the dialysis fiber and spread generously along 
both open ends of the hypodermic tube to provide a water-tight seal around the fused 
silica. This forced the perfusion buffer to travel in a path from the inlet opening along the 
dialysis membrane and out the outlet openings. 
The standard probe was housed in a cut 100 fiL pipette tip (not shown in Figure 2: 
Microdialysis Probe) filled with epoxy to prevent damage to the probe body both during 
placement and also during the experiments for the Acute Tolerance studies. The rat was 
allowed to run freely in a standard cage. The pipette tip, fixed at a measured distance 
from the microdialysis tip, also provided a guide as to how far the probe needed to be 
inserted in the experimental animal: full insertion of the probe in the guide cannula (placed 
during surgery) to the pipette tip determined the precise dorsal-ventral distance of 7 mm 
below the skull. The length of the exposed dialysis membrane in the probe was 2 mm 
which allowed collection of dopamine along the entire dorsal-ventral aspect of the nucleus 
accumbens. 
The microdialysis probe was inserted into the study animal under anesthesia (2% 
halothane and 80% oxygen) one day prior to the experiment. Then the animal was attached 
to the liquid swivel and placed in the experimental cage. Probes were perfused overnight 
with artificial cerebral spinal fluid (ACSF), containing in mM: KC1 2.4, NaCL 137, CaCl2 
1.2, MgCl2 1.2, NaH2P04 0.9, and ascorbic acid 0.08, at pH 7.4 at a flow rate of 
1 /rL/min by infusion pump. On the day of the experiment the flow rate was increased to 
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2 pL/min for at least half an hour prior to collection of the first sample. Samples were 
collected through fused silica lines by a fraction collector every 20 minutes for the 
duration of the experiment and were analyzed using HPLC. 
2.4 Behavioral Studies for Acute Tolerance Studies 
Rat behavioral data were collected in the standard experimental cages which were 
modified by the addition of four infrared detectors spaced evenly along the length 1.75 
inches from the cage floor. The Med-PC program (MED Associates & Thomas A. Tatham 
version 2) running on an IBM compatible computer recorded the number of non-consecutive 
beam breaks a rat made at five minute intervals until the conclusion ol the experiment. On 
the night previous to the experiment day (after microdialysis probe insertion) behavioral 
data were recorded for the rats placed in the cages to assess any circadian rhythm 
variations. 
2.5 Schedule and Drug Administration for Acute Tolerance Studies 
On the morning ol the study day, the ACSF was increased from the overnight flow 
rate ol 1 /tL/min to 2 pL/min lor at least half an hour prior to collection ol the first 
microdialysis baseline sample. Collection ol baseline behavioral information and baseline 
dopamine concentration levels at the nucleus accumbens was begun at the same time and 
continued lor two hours prior to the first bolus of study drug. As previously mentioned, 
behavioral data were collected at five minute intervals, and microdialysis samples were 
collected at 20 minute intervals. 
After a two hour baseline period, the first bolus ol 3 /tmol/kg of study drug— 
cocaine, cocaethylene, or isopropyl cocaine—was infused into the jugular catheter over 30 
seconds. This was immediately lollowed by a maintenance flow rate of the bolused drug 
at 17 fiL/min of the same 3 /zmol/mL solution. The maintenance rate was calculated to 
achieve an approximate blood plasma concentration goal of 200 ng/mL and was based on a 
reported clearance rate of 73.5 ±9.5 mL/min and 82.8 ± 7.4 mL/min for intravenous 
cocaine and cocaethylene respectively (Nobiletti et al., 1994). These clearance rates were 
not significantly different. Clearance was estimated as 80 ml/min for both compounds. 
200 ng/ml x 80 ml/min = 16 /ig/min infusion rate. Isopropyl cocaine clearance rates were 
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estimated to be similar though currently no studies have yet been done to quantity the 
pharmacokinetic properties ot this compound. 
Table 2: Study Drugs 
dm? salt MW active component MW infusion rate 
cocaine • HC1 339.9 303.4 17.3 /ig/min (51 nmol/min) 
cocaethylene • fumarate 491.5 317.4 25.1 /ig/min (51 nmol/min) 
isopropyl cocaine • HC1 368.0 331.5 18.7 /ig/min (51 nmol/min) 
MW: molecular weight 
Three hours after the initial bolus, the constant infusion of drug was stopped and a 
challenge of 3 ^mol/kg cocaine in a 3 fdmol/mL solution was given intravenously with 
microdialysis and behavioral data continuing for one hour. The rats were then 
immediately anesthetized with 0.12 mL/100 gm equithesin intravenously through the 
jugular catheter and transported in a closed box with halothane to be sacrificed. The 
plasma was collected in a vacutainer containing potassium oxalate and sodium fluoride, 
vortexed for 10 seconds, and centrifuged for three minutes. The plasma was then removed 
and frozen for later extraction and analysis. The brains were removed and placed in 
formalin; later, 100 //m coronal sections were made by vibratome and stained with cresyl 
violet to verify probe placement. Drug concentrations in the rat during the experiment were 
verified by plasma analysis using extraction, and HPLC was performed in Dr. Jatlow’s 
laboratory using a method previously described (Jatlow and Nadim, 1990). 
2JS Chromatography 
Determination of dialysate dopamine content was performed using liquid 
chromatography with microbore columns packed in the laboratory with 3 fdm Spherisorb 
ODS2 particles and electrochemical detection (Eapp: +0.6 V vs Ag/AgCl reference, 
Bioanalytical System, West Lafayette, IN). The output was to a strip chart recorder. 
Mobile phase consisted of 9 mg/L sodium monophosphate, 320 mg/L sodium 
octanesulfonate, 120 mg/L methanol, 0.1 mM disodium EDTA, and 300 fdL triethylamine. 
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The pH was adjusted with sodium hydroxide or phosphoric acid until its value was 5. 
Mobile phase was pumped using an ESA 580 pump at a flow rate of 0.200 mL/min and 
samples were injected by ESA 465 autosampler. 
2.7 Isopropyl Cocaine Dosing Studies in the Anesthetized Rat 
Dopamine response studies comparing various dosages of isopropyl cocaine to 
cocaine were conducted with chloral hydrate anesthetized rats using a microdialysis 
procedure previously described (Bradberry et al., 1993). An intraperitoneal injection of 
400 mg/kg chloral hydrate was given to the rat; additional chloral hydrate supplement was 
provided as needed to maintain surgical anesthesia for the entire duration of the 
experiment. After chloral hydrate administration, the rat was placed in the flat skull 
position, and the skull was exposed as described in section 2.2, Surgery for Acute Tolerance 
Studies. No guide cannula was placed as in the awake animal experiments; rather, a 
standard probe was lowered slowly to the nucleus accumbens—AP +1.7 mm, L -1.5 mm, 
and V -8.3 mm Irom bregma. The probe position was secured with methacrylate adhesive. 
The rat was then removed from the stereotaxic frame for the experiment. Rat body 
temperature was maintained with an electric heating pad set at 37° C. The perfusion buffer 
for microdialysis was identical to that used in the experiment described earlier 
(section 2.3, Microdialysis) and flowed at 2 /tL/min. Samples were collected every 20 
minutes. A stable baseline dopamine level was confirmed by a two hour collection period 
before drug infusion. After the baseline period, cocaine at 3 /imol/kg; isopropyl cocaine at 
6, 12, or 24 //mol/kg; or both cocaine at 3 /tmol/kg and isopropyl cocaine at 12 /rmol/kg 
was infused in the rat by tail vein injection over 30 seconds. Dopamine concentrations in 
the dialysate were measured for another two hours as described in section 2.6, 
Chromatography. 
2& Chronic Tolerance Studies 
These rats were prepared with a jugular catheter as described in section 2.2, Surgery 
for Acute Tolerance Studies. In addition, an Alzet 2ML1 osmotic pump was implanted 
subcutaneously on the back, midline and slightly posterior to the scapulae. The 2ML1 
pump solution was released at a rate of 10.0 pL per hour for seven days which delivered 
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drug into the free jugular vein via silastic medical grade tubing. Thus bilateral jugular 
veins were catheterized; venous blood flow occurred through collaterals. Care was paid to 
correct filling, incubation, and sterile handling of the pump as prescribed by Alzet. A free 
loop of silastic tubing was left exposed at the back of the neck after pump implantation to 
allow ligation and termination of continuous fluid infusion during the experiment. The 
minipump was filled with sterile water (control), cocaine solution, cocaethylene solution, 
or isopropyl cocaine solution in amounts given in the following Table 3: Minipump Study 
Drugs. Desired plasma levels were 85 to 90 ng/ml for the cocaine and cocaethylene 
animals. As can be seen, isopropyl cocaine was infused at one half the rate of the other two 
test drugs because of limited availability of this specially synthesized compound. The 
experimental design did not permit verification of plasma levels. 
Table 3: Minipump Study Drugs 
dru? salt MW active component MW infusion rate 
cocaine • HC1 339.9 303.4 7.7 /rg/min (22.6 nmol/min) 
cocaethylene • fumarate 491.5 317.4 11.1 pglmin (22.6 nmol/min) 
isopropyl cocaine • HC1 368.0 331.5 4.6/Jg/min (11.3 nmol/min) 
MW: molecular weight 1.68 mL total delivered by pump for week at 10 pL per hour 
No microdialysis was conducted on these animals. Behavioral data were collected 
overnight on the sixth day after implantation of mini-pump. The next morning an hour of 
baseline behavior was collected after which the continuous infusion by minipump was 
stopped by ligation of tubing running to the jugular catheter. A washout period of two 
hours to clear plasma of the chronically infused drug was followed by a bolus of 3 
/rmol/kg cocaine via jugular catheter and one more hour of behavioral data collection. The 
rats were then sacrificed with an overdose of equithesin or chloral hydrate. 
During the week of constant infusion, the jugular catheter connecting to the outside 
by way of the L pwece and dental acrylic was flushed daily with heparinized saline to 
maintain patency. Animals that appeared to be in distress after the surgery were sacrificed 
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before the scheduled experiment date. Rats were housed individually and given free access 
to food and water. 
2.9 Data Analysis 
Dopamine levels were calculated as femtomoles per microliter lor statistical 
analysis (uncorrected for probe recovery). One way repeated measures analysis of variance 
(ANOVA) was used to determine if administration of drug produced a significant change in 
dopamine levels or behavioral response within a group receiving a particular treatment. 
Two way repeated measures ANOVA was used to determine if there was a significant 
difference between experimental groups. An unpaired, two-tailed, Student’s t-test was 
used to compare activity after cocaine challenge between groups. The level of statistical 
significance was set at p < 0.05. All graphs represent dopamine data as a percentage ot 
baseline. The mean of the three points prior to drug administration was used to determine 
the pre-drug baseline. 
3. RESULTS 
3.1 Results from Acute Tolerance Studies 
Some animals were sacrificed before drug challenge at the end of continuous 
cocaine infusion in order to measure plasma drug levels. Mean plasma cocaine levels were 
481 ±66 ng/mL cocaine {n = 9) which were different from initially calculated. The target 
plasma drug concentration was 200 ng/mL which is slightly less than half ot measured 
plasma cocaine levels. This difference in plasma drug levels may be due in part to 
differences in anesthesia which the rats in this experiment were exposed to compared to the 
one on which we based our calculations (Nobiletti et al., 1994). 
The acute tolerance studies consisted of an initial bolus of cocaine, cocaethylene, or 
isopropyl cocaine followed immediately by a three hour infusion phase; all rats received a 
cocaine challenge at the end of the infusion. Microdialysis results from the group receiving 
a constant infusion of cocaine from times 0 to 180 minutes after bolus injection are 
presented in Figure 3. Results from the group receiving a constant infusion of cocaethylene 
is shown by Figure 4, and those for the isopropyl cocaine group are seen in Figure 5. Table 4: 
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Absolute Microdialysis Basal Levels presents basal dopamine values for the three groups which 
did not differ significantly. 
Large increases in dopamine levels were seen with an initial bolus of drug 
(3 /jmol/kg) in the animals receiving cocaine and cocaethylene but not with isopropyl 
cocaine. Using repeated measures ANOVA, there was a statistically significant increase in 
dopamine concentration in the nucleus accumbens starting Irom 40 minutes prior until 20 
minutes loilowing bolus 1 administration of cocaine (F = 11.174, p = 0.0006); dopamine 
levels reached 163.5 ± 19.0% of baseline levels. Comparing over time starting from the 
same 40 minutes of baseline samples immediately prior to drug bolus until 20 minute 
after cocaethylene administration, statistical significance was seen {F = 4.823, p = 0.021) 
with a mean dopamine level of 171.7 ± 25.17%. However, administration of isopropyl 
cocaine resulted in no significant increase in nucleus accumbens dopamine levels {F =0.088, 
p= 0.9168). 
Table 4: Absolute Microdialysis Basal Levels 
dray mean ± S.E.M. ifmo/JuL) n 
cocaine 0.54 ±0.06 11 
cocaethylene 0.65 ± 0.06 10 
isopropyl cocaine 0.36 ± 0.05 6 
Mean values measured in femtomoles per microliter (fmol//iL) 
Basal values were not significantly different between groups (p> 0.14) 
In order to determine the impact of the cocaine challenge following the 
bolus/infusion pretreatment, repeated measures ANOVA of the data—corresponding to 40 
minutes before cocaine challenge until 20 minutes after the challenge—was performed. 
There was no significant effect in the group receiving a constant infusion of cocaine 
{F= 2.191, p = 0.1379) or in the cocaethylene group (F= 2.444, p = 0.1151), but the change 
was statistically significant in the isopropyl cocaine group (F = 8.349, p = 0.0185) yielding 
a mean value of 168 ± 17.7% of the immediately preceding baseline (one hour before 
challenge) (Please refer to Figure 6). The baseline immediately preceding challenge was 
used rather than the one from times -60 to 0 minutes because of differences in steady-state 
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dopamine levels between the two; the interest was in the change to a cocaine challenge from 
the immediate pre-challenge state. Cocaine animals had a stable, elevated dopamine level 
during the three hour drug exposure; cocaethylene animals had a decreasing and then 
increasing level. Though the trend was an increase in dopamine levels in all three groups 
after cocaine challenge, the only significant increase was seen with the isopropyl cocaine 
group. A statistically significantly response to the challenge is expected in animals that do 
not have tolerance to cocaine, as seen in drug naive animals and rats pretreated with 
isopropyl cocaine. 
The effects of the pretreatment study drugs (cocaine, cocaethylene, and isopropyl 
cocaine) on the dopamine levels over time is different in each case. As seen in Figure 7, a 
bolus and constant infusion of cocaine causes a stable elevation of dopamine concentration 
throughout the maintenance phase of the experiment. Cocaethylene causes an immediate 
peak in dopamine levels after the loading dose is given, but then drops to baseline levels 
by two hours of constant infusion at which time the dopamine levels begin to rise again. 
Isopropyl cocaine at this low concentration, much like an inactive control, has virtually no 
effect on dopamine levels during the course of the experiment. 
For behavioral data, Figures 8-10 are labeled Cocaine Behavior, Cocaethylene 
Behavior, and Isopropyl Cocaine Behavior in a fashion analogous to that used in the 
microdialysis charts. The y-axis denotes the mean number of non-consecutive beam breaks 
made in a five minute period as described in section 2.4, Behavioral Studies for Acute 
Folerance Studies. Standard error bars are included. A combined graph of all three data 
sets combined without error bars follows in Figure 11. 
Statistically significant increases in activity were seen following the initial bolus of 
drug in the cocaine and cocaethylene groups but not in the isopropyl cocaine group. 
Increased activity from a mean of 1.1 ±0.1 counts per five minute time bin 60 minutes 
prior to bolus 1 to 7.5 ± 0.8 non-consecutive beam breaks per time bin in the 20 minutes 
following the first pre-infusion bolus (0 minutes post-injection) was statistically significant 
(F= 11.005, p = 0.0001) in the cocaine group using repeated measures ANOVA. For the 
group receiving cocaethylene as bolus 1, the change in behavior from a baseline of 2.3 ± 0.3 
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to a value of 6.2 ± 1.1 counts per five minutes was also significant {F = 2.587, p = 0.0012). 
There was no significant increase in activity in the isopropyl cocaine groups over the same 
time period (F = 0.899, p = 0.5672). 
By repeated measures ANOVA all study animals demonstrated significant increases 
in activity to cocaine challenge after a three hour maintenance phase on their respective drug 
(see Figure 12). The activity in the cocaine group increased to a maximum of 19.4 ± 3-5 
counts per five minutes following cocaine challenge compared to the preceding 60 minute 
mean of 11.5 ± 0.9 counts per five minutes; the trend over this period of time was 
statistically significant by repeated measures ANOVA (F = 5.402, p = 0.0001). Increased 
activity with cocaine challenge at the same time intervals was also statistically significant 
in both the cocaethylene group from 2.8 ± 0.4 to 8.4 ± 1.7 counts per five minutes (F = 
2.259, p= 0.0101) and in the isopropyl cocaine group from 0.7 ± 0.2 to 6.0 ± 1.2 counts 
per five minutes (F = 2.218, p = 0.0155). 
With two way repeated measures ANOVA, there were no significant differences in 
activity when comparing between groups from 15 minutes before the cocaine challenge 
(165 minutes post-injection of bolus 1) to 15 minutes after cocaine challenge. However, 
when comparing the maximal locomotor response of rats in five minute time periods after 
cocaine challenge using an unpaired, two-tailed t-test, there was a statistically significant 
difference between cocaine and cocaethylene groups {p = 0.0095) and between cocaine and 
isopropyl cocaine groups (p = 0.0372), but not between cocaethylene and isopropyl cocaine 
groups (p = 0.5024). The absolute activity of each groups is shown in Figure 12. Figure 13 
shows the amount of locomotor change seen in each group after a cocaine challenge. 
32 Results from Isopropyl Cocaine Dosing Studies 
The purpose of these experiments was to determine the dose of isopropyl cocaine 
that would elicit an equivalent dopamine response in the nucleus accumbens as seen with 
3 //mol/kg cocaine in the anesthetized rat. This has never been studied previously. 
One group of rats received cocaine at 3 //mol/kg, another group received isopropyl 
cocaine at 6 pmol/kg, and a third was treated with isopropyl cocaine at 12 /zmol/kg. The 
results from these three groups are shown in Figure 14. The dopamine increases in the 
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nucleus accumbens when compared to baseline values were statistically significant in the 
3 ^mol/kg cocaine group {F = 17.916, p = 0.0133); the mean change in this group was 
441.68 ± 93.55%. Dopamine levels alter a bolus ol isopropyl cocaine at 6 /imol/kg 
peaked at 185.10 ± 27.66%; however, this was not statistically significant (F = 3.992, 
p=9.\\GA). A bolus of 12 /imol/kg resulted in a mean dopamine response ol 
236.06 ± 13.55% which was significant (F = 28.344, p = 0.006). In another group of three 
animals given a bolus ol 24 pinol/kg isopropyl cocaine, two died immediately. Thus this 
dosage was abandoned, and the only surviving rat showed a nucleus accumbens dopamine 
response of 362.07% baseline after injection. A challenge ol both 3 /nnol/kg cocaine and 
12 /^mol/kg isopropyl cocaine together resulted in a response of 497.98 ± 39.51% ol 
baseline in two rats. Thus it did not appear that the concurrent presence of isopropyl 
cocaine diminished the effect of cocaine. 
33 Results from Chronic Tolerance Studies 
Figures 15-22 in this section depict the behavior ol rats that have undergone a seven 
day continuous infusion of control (water), cocaine, cocaethylene, or isopropyl cocaine. 
Figures 15-18 document activity of the animals on the night before the experiments, and 
Figures 19—22 show the experimental session which included the cocaine challenge: the 
continuous infusion was stopped 120 minutes belore the cocaine challenge to allow 
sufficient time for clearance of drug, and a bolus of cocaine was given at time zero. 
There was a slight basal activation at night from cocaine and cocaethylene in the 
chronically treated animals that was not observed in the isopropyl cocaine or control 
groups. When using two way repeated measures ANOVA to analyze activity between groups 
at night beginning approximately one hour prior to darkness, there was no statistically 
significant difference between cocaine and isopropyl cocaine animals, cocaine and 
cocaethylene rats, cocaethylene and isopropyl cocaine subjects, or isopropyl cocaine versus 
control animals. There was a significant difference between cocaine and control animals at 
night (F = 1.622, p = 0.0012) and between cocaethylene and control groups (F = 1.313, 
p - 0.0472). On Figure 23, the differences in night activity between the groups are shown. 
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There was tolerance to subsequent cocaine challenge following chronic cocaine and 
cocaethylene treatments which was not seen with rats maintained chronically on isopropyl 
cocaine or water. A bar graph comparing the total activity per rat in the 5-20 minutes after 
cocaine challenge for cocaine-, cocaethylene-, and water-maintained animals is found in 
Figure 24. This period corresponds to the time of drug action. One way repeated measures 
analysis of variance of the data from 30 minutes pre- to 30 minutes post-challenge showed 
a significant increase in activity in the control group {F = 3.464, p = 0.0003). There was no 
significant increase in behavior following challenge in the group receiving seven days of 
continuous cocaine infusion (F = 0.735, p = 0.7129). The cocaethylene group also showed no 
statistically significant increase in activity (F = 0.769, p = 0.6792). In contrast to the 
cocaine and cocaethylene groups, the increase in activity was statistically significant in the 
isopropyl cocaine group {F = 3.023, p = 0.0023). Multifactorial ANOVA examining the 
total activity from 5-20 minutes per rat (see Figure 24) shows significant differences 
between the cocaine and control groups as well as between the cocaethylene and control 
groups. 
4. DISCUSSION 
4.1 Discussion Introduction 
The prevalence of cocaine abuse and its impact on society has necessitated the 
search for an effective therapy to cocaine addiction, a disease for which there are currently 
no good treatments. As methadone is able to blunt the effects of subsequent heroin use by 
inducing tolerance, an analogous compound aimed at producing cross-tolerance to cocaine 
may be useful in treating cocaine addiction. The search for a pharmacological treatment of 
cocaine addiction is the basis of this present study. 
These experiments examined the impact of acute and chronic treatment with 
cocaine, cocaethylene, and isopropyl cocaine on dopamine levels in the nucleus accumbens 
(Acute Tolerance Studies only) and also on locomotor behavior in the rat, and in 
particular, compared the effects of a subsequent cocaine challenge. It was hypothesized that 
continuous infusion of cocaine, cocaethylene, or isopropyl cocaine would blunt response to a 
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later bolus of cocaine; if this hypothesis were proved correct, then some or all of these 
compounds could potentially lead the way to a pharmacological management of cocaine 
addiction. As mentioned in section 1, Introduction, various studies have demonstrated 
tolerance with continuous cocaine administration (Emmett-Oglesby et al., 1993; Frank et 
al., 1992; Katz et al., 1992; Masserano et al., 1994). It appears Irom our results that we have 
demonstrated tolerance to some of the dosing regimens utilizing intravenous 
administration of drug as discussed below. 
Chronic treatment with cocaine and cocaethylene produced behavioral tolerance. 
Acute (three hours) maintenance of cocaine and cocaethylene produced a suggestion of 
neurochemical tolerance but no behavioral tolerance. Isopropyl cocaine produced little 
effect on the rats neurochemically or behaviorally though may be due to a dose used that 
was too small. 
42 Discussion for Acute Tolerance Studies 
Cocaine and cocaethylene are approximately equal in their ability to elevate 
extracellular dopamine levels with an acute bolus infusion as seen in Figure 7. The mean 
increase in dopamine levels in response to the initial cocaethylene bolus was similar to that 
elicited trom the cocaine in the Acute Tolerance studies which is consistent with an earlier 
study using anesthetized rats. (Bradberry et al., 1993). The initial isopropyl cocaine bolus 
resulted in no change in extracellular dopamine concentrations. Though isopropyl cocaine 
is approximately 50 times more selective for dopamine than lor serotonin transporters, it 
is known to be 15-25 times less active at both sites (Elsworth et al., 1993; Jatlow and 
Bradberry personal communication). Thus the lack of dopamine effect from isopropyl 
cocaine administration may be a dose effect. 
These microdialysis data are consistent with what is known about these three 
compounds as it relates to the rat. Cocaine and cocaethylene both elicit large extracellular 
dopamine responses; both were approximately equipotent in ability to increase dopamine 
levels from baseline. Isopropyl cocaine is clearly the least active of the three compounds in 
terms of extracellular dopamine response. 
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The time course of altered dopamine resulting from the three drugs appears to 
differ during the maintenance phase of the study. Cocaine causes a dopamine increase which 
is maintained at a stable level throughout the constant infusion. Cocaethylene causes a peak 
in the extracellular dopamine concentration 20 minutes after the loading dose, but this 
level drops constantly for 100 minutes. This may suggest that cocaethylene demonstrates 
tolerance to itself over time with respect to dopamine elevation. After 100 minutes, the 
extracellular dopamine concentration rises until the cocaine challenge. The exact cause for 
this increase in dopamine concentration after 100 minutes is currently unclear. Extracellular 
dopamine levels after isopropyl cocaine administration remains at baseline levels 
throughout the constant infusion which is expected since the initial bolus of isopropyl 
cocaine at 3 //mol/kg resulted in no effect on dopamine. 
No conclusions can be drawn regarding the effects of an acute maintenance of drug 
on neurochemical tolerance to subsequent cocaine because of the difficulties in interpreting 
the steady-state dopamine levels: dopamine levels are high throughout the experiment in 
the cocaine group, and dopamine levels are steadily increasing in the cocaethylene group— 
even before the cocaine challenge. Extracellular dopamine levels increased after the cocaine 
challenge in all groups. Using one way repeated measures ANOVA, the cocaine and 
cocaethylene groups showed no statistical change when comparing dopamine levels before 
and after cocaine challenge. This may be a result of acute neurochemical tolerance since the 
effect of the cocaine bolus resulted in minimal dopamine elevation, or in the case of 
cocaine, it may be due to the fact that all cocaine receptors were saturated which would 
imply that any additional cocaine administered (such as the challenge) would have no 
effect on the animals. 
When examining behavioral response to the initial bolus of drug, there was a 
statistically significant increase in behavior with cocaine and cocaethylene groups (see 
Figure 11). This behavioral activation was not seen with isopropyl cocaine suggesting again 
that this compound is less potent than cocaine and cocaethylene when examining nucleus 
accumbens dopamine activation or locomotor activation at these dosages. Also seen is that 
the behavioral and neurochemical effects are consistent—or parallel—within this 
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experimental paradigm: cocaine animals exhibited increasing behavioral activation during 
the maintenance phase while during that same time dopamine was constantly elevated 
above pretreatment levels; cocaethylene animals had falling dopamine levels during early 
maintenance and showed locomotor activity during that same period that tell to 
pretreatment levels. 
The behavioral trends in cocaine, cocaethylene, and isopropyl cocaine groups were 
similar after a cocaine challenge in the Acute Tolerance studies. The cocaine infusion 
group showed greater absolute behavioral activation with a cocaine challenge than the other 
two groups. While cocaine and cocaethylene bind the dopamine transporter equipotently, 
their main difference is a relatively greater affinity of cocaine for the serotonin transporter 
than cocaethylene and isopropyl cocaine. This may result in serotonin-related 
augmentation of behavior from cocaine as described in previous studies (Cameron and 
Williams, 1994; Parsons et al., 1996). The differences in dopamine and serotonin 
transporter selectivity could account for the increased behavioral activation seen in the 
cocaine bolus/infusion group compared to animals receiving cocaethylene or isopropyl 
cocaine bolus/infusion. 
The analysis of data from the Acute Tolerance studies yielded no definite 
evidence for the development of tolerance in a three hour period. These data were difficult 
to interpret because of the unstable locomotor activity levels immediately prior to 
challenge in the cocaine group. Even during the maintenance phase of the experiment, the 
cocaine-treated rats showed continually increasing behavioral activation. This phenomenon 
was not seen with the cocaethylene-treated rats; their activity returned to baseline during 
the three hour infusion, and they responded no differently to a cocaine challenge than the 
isopropyl cocaine rats (who were treated with such a small dose of isopropyl cocaine that 
it was presumed to have been equivalent to placebo). Thus, acutely, it can be concluded 
that cocaethylene causes less behavioral activation than cocaine. 
43 Discussion for Isopropyl Cocaine Dosing Studies in the Anesthetized Rat 
In order to compare the potency of isopropyl cocaine with cocaine, the experiments 
on chloral hydrate anesthetized rats were conducted (see Figure 14). While a dose of 
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isopropyl cocaine at 6 /tmol/kg resulted in an extracellular dopamine concentration 
increase that was not statistically significant, 12 /miol/kg yielded a statistically 
significant response. However, even at this dosage, the maximal response was a mean ol 
236.06 ±13.35% baseline for the group—much less than the 441.68 ± 93.55% of baseline 
response elicited by a cocaine challenge. When the administered dose was doubled to 24 
/tmol/kg, two of the three rats died immediately after injection. Thus, this line ol pursuit 
was abandoned with the conclusion that the lethal dose of isopropyl cocaine was less than 
the dose required to elicit a dopamine response similar to that lound alter cocaine infusion 
in chloral hydrate anesthetized rats. Cocaethylene has also been previously described as 
having a lower lethal dose than cocaine (Hearn et al., 1991). It is currently unclear why the 
cocaine analogs appear to be more toxic than the parent compound. 
Peak response to cocaine was significantly greater lor the chloral hydrate 
anesthetized rats than for the awake animal. Our data show that a bolus ol 3 /imol/kg 
cocaine via jugular catheter in a previously drug-naive animal increases dopamine levels in 
the nucleus accumbens to a statistically significant degree Irom baseline. It is interesting to 
note that the previous studies using chloral hydrate anesthetized rats at the same challenge 
doses (though with only a bolus and no infusion) showed a statistically significant increase 
in nucleus accumbens dopamine levels ranging from 304% to 400% of baseline while the 
present study with awake animals responded with an increase to only 163.5 ± 19.0% of 
baseline (Bradberry et al., 1993; Bradberry and Roth, 1989; Jatlow et al., 1991). The 
difference in dopamine elevation when comparing awake and anesthetized rats receiving 
the same doses of drug was also demonstrated in these studies and might be a consequence 
of a drug interaction between cocaine and chloral hydrate though the exact mechanism is 
currently unclear. The presence of chloral hydrate seems to augment the extracellular 
dopamine response in the nucleus accumbens. 
4.4 Discussion for Chronic Tolerance Studies 
Doses for the seven day constant infusion studies were much less than that given in 
the acute trials (Table 3: Minipump Study Drugs in Section 2.8: Chronic Tolerance Studies). 
Estimated plasma concentrations were between 85 and 90 ng/ml for cocaine and 
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cocaethylene animals; plasma concentrations were estimated to be approximately 47 
ng/ml for the isopropyl cocaine rats—the isopropyl cocaine animals were given a dose hall 
that of animals in the other treatment groups due to limited availability of this specially 
synthesized compound—though these target plasma concentrations may be underestimates 
as described in section 3.1, Results from Acute Tolerance Studies. Plasma concentrations 
were less hut sustained lor a greater amount of time when the seven day constant infusion 
study is compared to the three hour study. There was no statistically significant increase in 
activity subsequent to cocaine challenge in the chronically maintained cocaine and 
cocaethylene groups. Thus it appears that behavioral tolerance was achieved in these two 
groups. On the other hand, behavioral activation by a subsequent cocaine challenge was seen 
with a statistically significant increase in activity for the animals that were subjected to the 
control or to isopropyl cocaine for a week. This suggested that no behavioral tolerance was 
achieved lor either of these groups at the maintenance levels provided. 
While it is clear that there is little difference in the behavior after challenge 
between control and isopropyl cocaine groups using these dosages, it is unclear whether the 
amount of isopropyl cocaine given was enough to produce a physiologically significant 
alteration in response to a cocaine challenge. It is possible that the plasma levels of the 
isopropyl cocaine during the week of infusion were too low to be able to effect a 
subsequendy change in behavior. Possibly a higher dose of isopropyl cocaine than we had 
employed—but a less than lethal one—might produce tolerance. A compound like 
isopropyl cocaine that has more activity at the dopamine axis and relatively even less at 
the serotonin one than cocaethylene may have better promise as a drug used to treat cocaine 
addiction since theoretically it would still decrease the cocaine-induced euphoria but be 
even less behaviorally activating than cocaethylene. 
45 General Discussion 
From these studies it appears that neurochemicai and behavioral tolerance to 
cocaine develops at different times with respect to length of continuous cocaine or 
cocaethylene infusion required. With cocaine and cocaethylene pretreatment, the ability of 
a cocaine challenge to elevate extracellular dopamine levels was reduced within three hours 
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of constant infusion (though it is not clear whether true tolerance was achieved as described 
in section 4.2, Discussion for Acute Tolerance Studies). By giving rats a constant infusion of 
drug—cocaine or cocaethylene—lor seven days, behavioral tolerance was observed. 
Throughout these experiments, isopropyl cocaine at the dosages used did not display an 
ability to produce cross-tolerance to subsequent cocaine administration neurochemically or 
behaviorally though this may be a result of the low potency ol this compound (as measured 
by extracellular dopamine concentrations and locomotion) compared to the other two and 
the relatively low doses used. In fact, isopropyl cocaine-treated rats displayed the same 
behavior in the seven day continuous infusion experiments as the control group. 
The schedule of drug administration as well as the dosage play a significant role in 
the effect of a subsequent cocaine challenge. When rats were given the pretreatment of 
120 jUmol/kg cocaine daily by osmotic minipump and subject to the same trials after one 
or seven days of withdrawal, tolerance was observed (King et ai, 1992). A pretreatment 
schedule of cocaine given at 60 /rmol/kg three times a day was found to produce tolerance 
by day two which remained at 60% of baseline from days four through 10 (Emmett- 
Oglesby et ai, 1993). Acute tolerance to cocaine has also been reported to occur in humans 
(Foltin and Fischman, 1991; Foltin et al., 1990). While tolerance has been observed in 
animal trials, the exact parameters of drug administration to achieve either state 
successfully are still under study. In general, it is believed that a constant infusion of a pre¬ 
challenge drug, in this case cocaine or cocaethylene, causes tolerance. 
While previous experiments have confined themselves to higher doses of the study 
medications, possibly because drug administration was not intravenous and dius resulted in 
lower bioavailability of drug, this present study used 3 /zmol/kg for the first bolus—the 
loading dose—followed by 3 /imol/hour for three hours in the acute studies. The seven day 
continuous drug infusion and behavior studies used 32.6 /rmol/day for the cocaine and 
cocaethylene studies; the pretreatment was 16.3 ^mol/day for isopropyl cocaine. Drug 
doses for present chronic administration studies were only slightly less than used in 
previously reported trials. Even with these lower doses, tolerance was still observed using 
these dosing schedules. 
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Infusion rates in the present experiments were based on drug clearance which is 
equal to the product of the target steady state drug concentration and the total body 
clearance of compound. Clearance rates for intravenously administered cocaine and 
cocaethylene have been previously described as 73.5 ± 9.5 ml/min and 82.8 ± 7.4 ml/min 
respectively (Nobiletti et al., 1994). Isopropyl cocaine clearance rates are currently 
unknown and could only be presumed at present. 
Human states of euphoria derived from these drugs clearly cannot necessarily be 
equated with the behavioral activation seen in rats. At present, behavioral measurements 
such as the amount of grooming, locomotor activity, or other stereotypical movements are 
a popular method for determining the level of response achieved by drug administration. 
Microdialysis is a method to quantify the neurochemical drug response. However, it is 
uncertain how well these measurements might correlate with euphoric states. The 
importance of examining dopamine concentrations at the nucleus accumbens is suggested 
by studies showing that dopaminergic projections to the nucleus accumbens are required for 
the development of cocaine self-administration (Roberts and Koob, 1982). Self- 
administration animal paradigms may better reflect the ability a certain drug has in 
causing euphoria in people and may be the next step in future studies. And of course, this is 
one of the goals of current drug studies. We want to understand how compounds such as 
cocaine cause euphoria and tolerance because we wish to discover methods by which we can 
modulate these responses in humans. In this way, we may be able to find better modalities 
to treat cocaine abuse. Rat drug self-administration has been utilized with some success. 
One study suggested that rats titrate the amount of cocaine during self-administration to 
maintain a fairly constant, elevated dopamine level in the nucleus accumbens (Pettit and 
Justice, 1989); this leads us to believe that the reinforcing properties of cocaine are 
specifically related to extracellular dopamine levels in the nucleus accumbens. Another 
study using self-administration was shown to demonstrate no difference in the 
development of tolerance compared to continuous or intermittent drug administration 
schedules (Emmett-Oglesby et al., 1993). The Emmett-Oglesby et al. study simply 
explored another schedule of drug administration and its relationship to the development 
* 
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of tolerance; it did not elucidate the relationship between the state of drug tolerance, once 
achieved, and the subsequent effects it had on behavior. It may he interesting to ask the 
question: how different are the rates of self-administration when comparing a group of rats 
that has developed neurochemical or behavioral tolerance to a control group. Then we 
begin to examine the concept of tolerance as it relates to craving and possibly to euphoria. 
4j6 Conclusion 
In summary, the Chronic Tolerance studies showed that behavioral tolerance was 
seen in rats pretreated with cocaine or cocaethylene when challenged with cocaine; die 
behavior of the isopropyl cocaine group appeared to be no different than that of the control. 
Rats pretreated with three hours of cocaine or cocaethylene in the Acute Tolerance studies 
showed a decreased change in dopamine levels due to a cocaine challenge compared to 
isopropyl cocaine animals; because these data are difficult to interpret it cannot be 
definitively stated that tolerance was observed though tolerance is certainly suggested. 
There was no behavioral tolerance seen to a cocaine challenge during the Acute Tolerance 
study. However, during the Acute Tolerance study, it was observed that cocaethylene 
maintained animals displayed activation that was not sustained (both neurochemically and 
behaviorally) suggesting that cocaethylene may produce acute tolerance to itself. In the 
Isopropyl Cocaine Dosing Studies in the anesthetized rat, the extracellular dopamine 
response seen was found to be about four times that seen in awake rats when given a cocaine 
challenge. Isopropyl cocaine was much less potent than cocaine on eliciting a 
neurochemical change: the amount of isopropyl cocaine required to increase dopamine 
concentrations in the nucleus accumbens the same amount as seen when an anesthetized rat 
was given a challenge of 3 /rmol/kg cocaine appears to be greater than the lethal dose. The 
dopamine response to isopropyl cocaine at 12 /rmol/kg was still only 236 ± 13.33% of 
baseline in contrast to the 441.68 ± 93.55% of the baseline value seen with 3 /rmol/kg 
cocaine. 
Behavioral tolerance to cocaine can be achieved with a chronic cocaethylene pre¬ 
treatment. The characteristics of cocaethylene show some promise as a model for possible 
pharmacological therapies for cocaine addiction: as known previously, cocaethylene is 
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more selective lor dopamine than serotonin when compared to cocaine; this cocaine analog 
is cleared more slowly and has a longer half-life than cocaine; and as seen with the Acute 
Tolerance studies, it is less activating than cocaine acutely. An examination of cocaine and 
the two cocaine analogs at different doses or drug administration schedules may bring out 
more ol the unique qualities that each compound possesses. Further studies, perhaps 
utilizing a self-administration paradigm, may answer some of these interesting and 
important questions. 
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5. FIGURES AND GRAPHS 
Figure 1: Cocaine, Cocaethylene and Isopropyl Cocaine Structures 
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Figure 2: Microdialysis Probe 
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Figure 3: Mean values (± SEM) of extracellular dopamine response to IV boluses of 
cocaine (3 /rmol/kg) at times 0 and 180 with an intervening constant infusion of cocaine 
(51 nmoL/min) from times 0-180 minutes (n = 11). 

Tobias T. Lee Yale University School of Medicine Thesis Page 27 
Cocaethylene Microdialysis (n=10) 
250 -i 
Figure 4: Mean values (± SEM) of extracellular dopamine response to IV bolus ot 
cocaethylene (3 /imol/kg) at time 0 followed by a constant infusion of cocaethylene 
(51 nmol/min) until time 180 minutes and challenged with a bolus of cocaine 
(3 /tmol/kg) at time 180 minutes (n - 10). 





Figure 5: Mean values (± SEM) of extracellular dopamine response to IV bolus of 
isopropyl cocaine (3 /imol/kg) at time 0 followed by a constant infusion of isopropyl 
cocaine (51 nmol/min) until time 180 minutes and challenged with a bolus of cocaine 
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250 -i 
Dopamine Levels in Nucleus Accumbens 
Percentage increase from pre-challenge baseline 
200 - 
Dopamine Levels 
in Nucleus Accumbens 
Following cocaine 
challenge (t = 0) 
Pretreatment Group Drug Naive Rat 
Figure 6: Mean (± SEM) extracellular dopamine concentrations after IV challenge of 
cocaine (3 /imol/kg) at time 200 minutes as a percentage of immediately preceding 
baseline (times 140 to 180) lor rats pretreated with a 3 hour infusion of cocaine, 
cocaethylene, and isopropyl cocaine. Far right graph shows mean (± SEM) extracellular 
dopamine concentrations alter IV challenge of cocaine (3 ^mol/kg) at time 0 (drug naive 
rat) as a percentage of immediately preceding baseline. Cocaine- and cocaethylene- 
maintained rats show similar response trends while isopropyl cocaine- and drug-naive-rats 
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Constant infusion of drug 
Figure 7: Mean values (± SEM) of extracellular dopamine response to IV bolus/infusion 
of cocaine, cocaethylene, or isopropyl cocaine (3 /imol/kg bolus and 51 nmol/min 
infusion) at time 0 until time 180 minutes and challenged with cocaine (3 /rmoL/kg) at 
time 180 minutes. 
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Cocaine Behavior (n = 32) 
Figure 8: Mean values (± SEM) ol non-consecutive beam breaks measuring locomotor 
activity subsequent to IV bolus of cocaine (3 /Jmol/kg) at time 0 and time 180 minutes with 
a constant cocaine infusion (51 nmol/min) from time 0 to time 180 minutes (n = 32). 
Cocaethylene Behavior (n=20) 
Figure 9: Mean values (± SEM) of non-consecutive beam breaks measuring locomotor 
activity subsequent to IV bolus of cocaethylene (3 /imol/kg) at time 0 minutes followed by 
infusion of cocaethylene (51 nmol/min) until time 180 minutes and challenged with 
cocaine (3 /tmol/kg) at time 180 minutes {n = 20). 
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Isopropyl Cocaine Behavior (n = 10) 
Figure 10: Mean values (± SEM) of non-consecutive beam breaks measuring locomotor 
activity subsequent to IV bolus of isopropyl cocaine (3 /imol/kg) at time 0 minutes 
followed by infusion of isopropyl cocaine (51 nmol/min) until time 180 minutes and 
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Behavior Graphs Combined 
Standard error bars omitted for clarity 
Figure 11: Mean values of non-consecutive beam breaks measuring locomotor activity 
subsequent to an IV bolus/infusion of cocaine, cocaethylene, or isopropyl cocaine (3 
/imol/kg bolus and 51 nmol/min infusion) until time 180 minutes and challenged with 

















Tobias T. Lee Yale University School of Medicine Thesis Page 33 




after Cocaine Challenge 
Cocaethylene (n=20) Isopropyl Cocaine (n=10) 
r 25 
Maximal Behavioral 
Response Following Cocaine 
Challenge (t = 0) 
-15 
Cocaine (n=32; t=0) 
Pretreatment Group 
Drug Naive Rat 
Figure 12: Left three graphs show mean (± SEM) locomotor activity as measured by 
nonconsecutive infrared beam breaks during a five minute period of greatest activity after 
IV challenge of cocaine (3 /xmol/kg) at time 180 minute for rats pretreated with cocaine, 
cocaethylene, and isopropyl cocaine. Far right graph shows mean maximal locomotor 
activity (± SEM) during a five minute period immediately after IV challenge of cocaine 
(3 /rmol/kg) at time 0 (drug naive rats) preceding maintenance in the cocaine group. 
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Pretreatment Group 
Figure 13: Mean change in locomotor activity from immediately preceding baseline (15 
minute period prior to challenge) as measured by nonconsecutive infrared beam breaks 
during a five minute period during the period of greatest activity after FV challenge of 
cocaine (3 /imol/kg) at time 180 minute for rats pretreated with cocaine, cocaethylene, and 
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Figure 14: Mean values (± SEM) of extracellular dopamine response to cocaine at 3 
/imol/kg {n = 5) compared to isopropyl cocaine at 6 /imol/kg (n = 5) and 12 /imol/kg (n = 5) 
doses in anesthetized rats. 

Page 36 Tobias T. Lee Yale University School of Medicine Thesis 
Mini-pump Behavior Night Control (n=9) 
30 n 
25 - 
Figure 15: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity starting approximately one hour before darkness on day 
six of a seven day control (water) infusion by mini-pump {n = 9). 
Mini-Pump Behavior Night Cocaine (n=7) 
Figure 16: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity starting approximately one hour before darkness on day 
six of a seven day cocaine (7.7 /tg/min; 22.6 nmol/min) infusion by mini-pump (« = 7). 
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Mini-pump Behavior Night Cocaethylene (n=6) 
Figure 17: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity starting approximately one hour before darkness on day 
six of a seven day cocaethylene (11.1 /rg/min; 22.6 nmol/min) mini-pump infusion {n - 6). 
Mini-pump Behavior Night Isopropyl Cocaine (n=6) 
Figure 18: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity starting approximately one hour before darkness on day 
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30 -i 
Mini-pump Behavior Control (n=9) 
25 - 
Figure 19: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity when a seven day infusion of control (water) was stopped 
at -120 minutes and a bolus of cocaine (3 ^rmol/kg) was given at time 0 minutes (n = 9). 
Mini-pump Behavior Cocaine (n=7) 
Figure 20: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity when a seven day infusion of cocaine (7.7 ^ig/min; 22.6 
nmol/min) was stopped at -120 minutes and a bolus of cocaine (3 /imol/kg) was given at 
time 0 minutes (n - 7). 
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Mini-pump Behavior Cocaethylene (n=5) 
Figure 21: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity when a seven day infusion of cocaethylene (11.1 /ig/min; 
22.6 nmol/min) was stopped at -120 minutes and a bolus of cocaine (3 /imol/kg) was given 
at time 0 minutes (« = 5)- 
Mini-pump Behavior Isopropyl Cocaine (n=6) 
Figure 22: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins 
measuring rat locomotor activity after seven day infusion of isopropyl cocaine 
(4.6/rg/min; 11.3 nmol/min) was stopped at -120 minutes and a bolus of cocaine 
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Pretreatment Group 
Figure 23: Mean total number of non-consecutive beam breaks (± SEM) over six hours of 
rats in various pretreatment groups (cocaine, cocaethylene, isopropyl cocaine, and control) 
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Locomotor Activity in Chronically Treated Rats 
Average 15 minute response per rat immediately alter cocaine challenge 













Figure 24: Total number of non-consecutive beam breaks (± SEM) from 5—20 minutes 
immediately following cocaine challenge (time 0). Rats are from various pretreatment 
groups (cocaine, cocaethylene, control, and baseline). 
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